Loading provider…
Loading provider…
Medical Oncology Physician in North Port, FL
NPI: 1003807645Primary Practice Location
SARASOTA MEMORIAL HOSPITAL - VENICE
2600 Laurel Rd E, North Venice, FL
Primary Employer
Florida Cancer Specialists & Research Institute - Cape Coral Cay West
flcancer.com
HQ Phone
Get M.D. Scott's Phone Numberphone_androidMobile
Get M.D. Scott's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
2001 - 2027
TX State Medical License
2000 - 2003
NC State Medical License
1996 - 2001

American Board of Internal Medicine
Medical Oncology
washington university
Biology
1987 - 1991
BS • Biology
1987 - 1991
Duke University Hospital
Residency • Internal Medicine
1995 - 1998
University of Texas Health Science Center at Houston/M D Anderson Cancer Center
Fellowship • Hematology and Medical Oncology
1999 - 2002
Duke University School Of Medicine
medschool.duke.edu
Medical School
Until 1995
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 85025Complete blood cell count (red cells, white blood cell, platelets), automated test | 746 | 3,538 |
| 2 | 36415Insertion of needle into vein for collection of blood sample | 737 | 3,076 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 697 | 2,300 |
| 4 | 85046Red blood count automated, with additional calculations | 412 | 1,030 |
| 5 | 99213Established patient office or other outpatient visit, typically 15 minutes | 396 | 538 |
Images in clinical medicine. Suppurative parotitis.
Authors: Lunin, S D, Moll, S
Journal: N Engl J Med
Lead Sponsor: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: nilotinib
Lead Sponsor: Gilead Sciences
Intervention / Treatment: DRUG: Placebo, DRUG: Rituximab, DRUG: Idelalisib